-
Aberrant EZHIP Expression Drives Tumorigenesis in Osteosarcoma
Study
EGAS00001007531
-
CLL Genome
Study
EGAS00000000092
-
Genomic and Transcriptomic Profiling of Colorectal Cancer in Swedish Patients
Study
EGAS50000000158
-
Whole-Genome and Transcriptomic Data from Colorectal Cancer Patients and Matched Healthy Controls in Sweden
Dataset
EGAD50000000155
-
DNA Methylation and Microbiome Profiles from Colorectal Cancer Patients and Healthy Controls
Dataset
EGAD50000000156
-
Personalized Onco-Genomic Project for pediatric and adolescent patients in British Columbia
Study
EGAS50000000433
-
Integrative genomic analyses reveal androgen-driven somatic alteration landscape in early-onset prostate cancer
Study
EGAS00001000400
-
Integrative sequencing reveals alterations in untreated and castration resistant prostate cancer
Study
EGAS00001000526
-
Whole genome sequencing and whole exome sequencing of DIPG tumors and matched normal tissue
Study
EGAS00001000575
-
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids
Study
EGAS00001000650
-
Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors
Study
EGAS00001000708
-
Combined targeting of BRD4-associated Promoter Activation and NFKB Immunomodulation in ARID1A-mutated Gastric Adenocarcinoma
Study
EGAS00001006397
-
RRBS data from TRACERx non-small cell lung cancer (NSCLC) tumours and matched normal adjacent tissue.
Study
EGAS00001006523
-
Follicular Lymphoma Whole Genome and Transcriptome Sequencing
Study
EGAS00001006646
-
Characterization of MCSP+ melanoma DCC and MelDCC lines
Study
EGAS00001006702
-
Characterization of chromatin accessibility in metastatic prostate cancer
Study
EGAS00001006698
-
Genomic profiling of subcutaneous patient derived xenograft models of solid childhood cancer
Study
EGAS00001006710
-
Childhood B-cell acute lymphoblastic leukemia genomic and transcriptomic data
Study
EGAS00001006863
-
The Landscape of N-6 Methyladenosine in Primary Localized Prostate Cancer
Study
EGAS00001006925
-
Multi-region RNA sequencing of tumour regions and tumour-adjacent normal lung tissue
Study
EGAS00001006517
-
Discovery of cancer prognostic markers based on comparison of gene expression in colorectal cancer samples.
Study
EGAS00001005068
-
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer
Study
EGAS00001005952
-
The ICGC-TCGA DREAM Somatic Mutation Calling - Tumour Heterogeneity Challenge
Study
EGAS00001002092
-
Global Anaplastic Thyroid Cancer Initiative
Study
EGAS00001002234
-
Molecular Subtype-specific Biomarkers Improves Colorectal Cancer Prognostication
Study
EGAS00001002376
-
Pharmacogenomic landscape of patient-derived cells informs precision oncology therapy
Study
EGAS00001002515
-
The interface of malignant and immunologic clonal dynamics in high-grade serous ovarian cancer
Study
EGAS00001002839
-
Combined gene expression and digital pathology identifies molecular mediators of T cell exclusion and immune suppression in ovarian cancer
Study
EGAS00001003487
-
Genomic and transcriptomic landscape of aggressive thyroid cancer
Study
EGAS00001003540
-
Cancer and germline exomes consisting of FASTQ paired-end reads from melanoma and lung cancer samples
Study
EGAS00001003723
-
The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer (CIN3+)
Study
EGAS00001005078
-
Immunogenomic landscape of hematological malignancies
Study
EGAS00001004444
-
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
Study
EGAS00001004406
-
The Molecular Landscape of Asian Breast Cancers Reveals Clinically Relevant Population-Specific Differences
Study
EGAS00001004518
-
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer (NABUCCO Cohorts 1 and 2)
Study
EGAS00001004521
-
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk paediatric cancer
Study
EGAS00001004572
-
Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
Study
EGAS00001004614
-
Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer
Study
EGAS00001004615
-
Accurate detection and classification of pediatric sarcomas based on cell-free DNA fragmentation patterns
Study
EGAS00001005127
-
Multi-institutional collaboration to characterize 5hmC in prostate cancer, both tumor biopsies and cfDNA.
Study
EGAS00001004942
-
The WID-EC test for the detection and risk prediction of endometrial cancer
Study
EGAS00001005033
-
The DNA methylome of cervical cells and risk of ovarian cancer
Study
EGAS00001005045
-
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples
Study
EGAS00001005055
-
Methylome sequencing of cell-free DNA and RRBS of solid tissue
Study
EGAS00001006020
-
Enhancer profiling to identify identifies epigenetic markers of endocrine resistance in metastatic castration resistant prostate cancer patients
Study
EGAS00001006161
-
Whole-Exome Sequencing analyses in tamoxifen-associated endometrial cancer
Study
EGAS00001006453
-
Gene signature for predicting homologous recombination deficiency in triple-negative breast cancer
Study
EGAS00001006518
-
PELICAN45 RNAseq Dataset
Study
EGAS00001006959
-
LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients
Study
EGAS00001007072
-
Melanoma_Til_Study_RNAseq
Study
EGAS00001000251